Anne Marie Salapatek
- Mild asthmatic patients consistently respond to natural, low dose, allergen challenge in an EECBy Deepen Patel, Nayven Patel, Joanne Lee, Peter Couroux, Rod Hafner and Anne Marie SalapatekDeepen Patel1Medical Affairs, Cetero Research, Mississauga, CanadaNayven Patel1Medical Affairs, Cetero Research, Mississauga, CanadaJoanne Lee2Research & Development, Cetero Research, Mississauga, CanadaPeter Couroux1Medical Affairs, Cetero Research, Mississauga, CanadaRod Hafner3Research & Development, Circassia Ltd., Oxford, United KingdomAnne Marie Salapatek2Research & Development, Cetero Research, Mississauga, Canada
- A new naturalistic asthma model in the environmental exposure chamber to study mild asthmatics safely and consistentlyBy Anne Marie Salapatek, Erin Beattie and Piyush PatelAnne Marie Salapatek1Research & Development, Inflamax Research, Mississauga, ON, CanadaErin Beattie1Research & Development, Inflamax Research, Mississauga, ON, CanadaPiyush Patel2CEO & Medical Director, Inflamax Research, Mississauga, ON, Canada
- QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamberBy Veit J. Erpenbeck, Anne Marie Salapatek, Piyush Patel, Deanne Carew, Gerald Dubois, Sheryl Perry and Michael LarbigVeit J. Erpenbeck1Primary Care, Novartis Pharma AG, Basel, SwitzerlandAnne Marie Salapatek2Clinical Research, Inflamax Research Inc, Toronto, ON, CanadaPiyush Patel2Clinical Research, Inflamax Research Inc, Toronto, ON, CanadaDeanne Carew3Primary Care, Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United KingdomGerald Dubois3Primary Care, Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United KingdomSheryl Perry3Primary Care, Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United KingdomMichael Larbig1Primary Care, Novartis Pharma AG, Basel, Switzerland
- Should patients with mild asthma be excluded from allergic rhinitis drug trials?By Anne Marie Salapatek, Peter Couroux, Victoria Nelson and Piyush PatelAnne Marie SalapatekR&D, Inflamax Research, Mississauga, ON CanadaPeter CourouxR&D, Inflamax Research, Mississauga, ON CanadaVictoria NelsonR&D, Inflamax Research, Mississauga, ON CanadaPiyush PatelR&D, Inflamax Research, Mississauga, ON Canada
- Comorbidity of allergic rhinitis and asthma to birch allergen in an environmental exposure chamberBy Victoria Nelson, Peter Couroux, Tara Sadoway, Piyush Patel and Anne Marie SalapatekVictoria NelsonR&D, Inflamax Research, Mississauga, CanadaPeter CourouxR&D, Inflamax Research, Mississauga, CanadaTara SadowayR&D, Inflamax Research, Mississauga, CanadaPiyush PatelR&D, Inflamax Research, Mississauga, CanadaAnne Marie SalapatekR&D, Inflamax Research, Mississauga, Canada
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
